The alternative role of 14-3-3 zeta as a sweeper of misfolded proteins in disease conditions

被引:42
作者
Kaneko, K [1 ]
Hachiya, NS [1 ]
机构
[1] Tokyo Med Univ, Dept Physiol 2, Tokyo 1608402, Japan
关键词
D O I
10.1016/j.mehy.2006.01.019
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Here, we propose a novel hypothesis that 14-3-3 zeta might act as a sweeper of misfolded proteins by facilitating the formation of aggregates, which are referred to as inclusion bodies. Studies on the localization of the 14-3-3 proteins in different types of inclusion bodies in the brain including neurofibrillary tangle in Alzheimer's disease, pick bodies in Pick's disease, Lewy body-like hyaline inclusions in sporadic amyotrophic lateral sclerosis, prion/florid plaques in sporadic/variant Creutzfeldt-Jakob disease, nuclear inclusions in spinocerebellar ataxia-1, and possibly Lewy bodies in Parkinson's disease suggest a close association of these diseases with 14-3-3 zeta. The highly conserved hydrophobic surface of the amphipathic groove in 14-3-3 zeta represents a general mechanism with diverse cellular proteins, and it may also allow for the molecular recognition of misfolded proteins by hydrophobic interaction in disease conditions. When the abnormal processing of misfolded proteins overwhelms the quality control systems of the cell, it is likely that 14-3-3 zeta is recruited to form deposits of protein aggregates with nonnative, misfolded proteins in order to protect the cell against toxicity. Hence, 14-3-3 zeta may be considered as an auxiliary therapeutic tool in the protein aggregation disorders. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:169 / 171
页数:3
相关论文
共 19 条
[1]   14-3-3 proteins in the nervous system [J].
Berg, D ;
Holzmann, C ;
Riess, O .
NATURE REVIEWS NEUROSCIENCE, 2003, 4 (09) :752-762
[2]   Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1 [J].
Chen, HK ;
Fernandez-Funez, P ;
Acevedo, SF ;
Lam, YC ;
Kaytor, MD ;
Fernandez, MH ;
Aitken, A ;
Skoulakis, EMC ;
Orr, HT ;
Botas, J ;
Zoghbi, HY .
CELL, 2003, 113 (04) :457-468
[3]   Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs [J].
Forman, MS ;
Trojanowski, JQ ;
Lee, VMY .
NATURE MEDICINE, 2004, 10 (10) :1055-1063
[4]   Parkinson's - Divergent causes, convergent mechanisms [J].
Greenamyre, JT ;
Hastings, TG .
SCIENCE, 2004, 304 (5674) :1120-1122
[5]   More than a 100-fold increase in immunoblot signals of laser-microdissected inclusion bodies with an excessive aggregation property by oligomeric actin interacting protein 2/D-lactate dehydrogenase protein 2 [J].
Hachiya, NS ;
Ohkubo, T ;
Kozuka, Y ;
Yamazaki, M ;
Mori, O ;
Mizusawa, H ;
Sakasegawa, Y ;
Kaneko, K .
ANALYTICAL BIOCHEMISTRY, 2005, 347 (01) :106-111
[6]   14-3-3ζ is an effector of tau protein phosphorylation [J].
Hashiguchi, M ;
Sobue, K ;
Paudel, HK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25247-25254
[7]   Zeta 14-3-3 protein favours the formation of human tau fibrillar polymers [J].
Hernández, F ;
Cuadros, R ;
Avila, J .
NEUROSCIENCE LETTERS, 2004, 357 (02) :143-146
[8]   Mechanism of substrate recognition by the chaperonin GroEL [J].
Houry, WA .
BIOCHEMISTRY AND CELL BIOLOGY, 2001, 79 (05) :569-577
[9]   14-3-3 proteins in Lewy body-like hyaline inclusions in patients with sporadic amyotrophic lateral sclerosis [J].
Kawamoto, Y ;
Akiguchi, I ;
Nakamura, S ;
Budka, H .
ACTA NEUROPATHOLOGICA, 2004, 108 (06) :531-537
[10]   14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains [J].
Kawamoto, Y ;
Akiguchi, I ;
Nakamura, S ;
Honjyo, Y ;
Shibasaki, H ;
Budka, H .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (03) :245-253